Nebula is free while in beta — browse the evidence map with no account.Open Nebula →
AEaH.aiEvidence · Intelligence

trial · primary record

MRI-guided adaptive stereotactic ablative body radiotherapy (SABR)

Liver Cancer

PhasePhase 2
StatusRECRUITING
SponsorUnknown
Enrolment62
Primary completion2030-01
Primary endpoint1-year Overall Survival (OS)
Registry IDNCT07223307

Provenance

  • Source: ClinicalTrials.gov
  • Fetched at: 2026-10-28T02:31:49.527Z
  • Licence class: attribution-required
  • Verdict: primary-source
  • Entity id: NCT07223307

This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.

Start monitoring — $199/monthAll trial records
MRI-guided adaptive stereotactic ablative body radiotherapy (SABR) — trial | AEaH